SERPINA1 and asthma: Considering that de Serres et al. estimated the prevalence of the M/S genotype to be 6.0% (2,671,230 out of 45,644,023 people) in the general Colombian population [20], our results suggest a possible enrichment of this AAT variant in the difficult-to-treat asthma population compared to the general Colombian population.